Cullinan Therapeutics, Inc.
CGEM
Revenue
0.00
0.000.00%
3 Months ChangeAssets
681.22M
▲231.79M▲51.57%
3 Months ChangeLiabilities
25.00M
▲1.23M▲5.18%
3 Months ChangeFree Cash Flow
-38.25M
▲12.91M▲25.23%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0000950170-24-114841
2024-09-17
Form 8-K
ID: 0000950170-24-107011
2024-08-08
Form 10-Q
ID: 0000950170-24-093320
2024-08-08
Form 8-K
ID: 0000950170-24-093314
2024-06-27
Form 8-K
ID: 0000950170-24-078554
2024-06-03
Form 8-K
ID: 0000950170-24-067662
2024-05-23
Form 8-K
ID: 0000950170-24-064025
2024-05-15
Form 10-Q
ID: 0000950170-24-060535
2024-05-15
Form 8-K
ID: 0000950170-24-060481
2024-04-29
Form 8-K
ID: 0000950170-24-049436